Best Paper Presentation (Poster)

Abstract ID Abstract Title Author
Clinical
515NHU175 Real-World Clinical Experience with Very Low-Dose Emicizumab Prophylaxis in Hemophilia A: A Single-Center Observational Study from a Tertiary Care Institution Dr. Kalpita Suresh Pai
Seth G S Medical College and KEM Hospital, Mumbai
565NHU192 Emicizumab as Adjunctive Therapy in Acquired Hemophilia A in a Resource-Limited Setting: A Single-Center Case Series of Four Patients Dr. Naman Lodha
Post Graduate Institute of Medical Education and Research, Chandigarh
Laboratory
438NHU152 Prenatal identification of severe haemophilia A in a female foetus: the importance of pedigree analysis and molecular diagnosis. Ms. Karishma Vyas
ICMR - NIIH, Mumbai
437NHU196 A Novel Emicizumab-Compatible Lateral Flow Immunoassay for Rapid Detection of Factor VIII Inhibitors Dr. Rucha Patil
ICMR - NIIH, Mumbai
434NHU150 Immunogenetic basis of factor VIII inhibitor development in severe haemophilia A patients: Integrated analysis of immune cell profiling, cytokine signatures, immune gene polymorphisms and whole exome sequencing Dr. Sharda Shanbhag
ICMR - NIIH, Mumbai
Musculoskeletal
416NHU143 Effect of In-person versus Home-based E-exercise Rehabilitation on Quality of Life in Persons with Haemophilia A receiving Emicizumab Dr. Smati Sambyal
University College of Physiotherapy, Faridkot
Multi-disciplinary Care: Nursing, Dental, Psychosocial
335NHU123 Optimizing Clotting Factor Concentrate Administration for Dental Interventions in People with Haemophilia: An Evidence-Based Approach Dr. Mathangi Kumar
Manipal College of Dental Sciences, Manipal